Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Cell-free DNA in newly diagnosed patients with glioblastoma - a clinical prospective feasibility study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Actively personalized vaccination trial for newly diagnosed glioblastoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Extracranial metastases in glioblastoma-Two case stories

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Glioblastoma multiforme (GBM) is the most common and devastating primary brain tumor among adults. Despite recent treatment progress, most patients succumb to their disease within 2 years of diagnosis. Current research has highlighted the importance of a subpopulation of cells, assigned brain cancer stem-like cells (bCSC), to play a pivotal role in GBM malignancy. bCSC are identified by their resemblance to normal neural stem cells (NSC), and it is speculated that the bCSC have to be targeted in order to improve treatment outcome for GBM patients. One hallmark of GBM is aberrant expression and activation of the epidermal growth factor receptor (EGFR) and expression of a deletion variant EGFRvIII. In the normal brain, EGFR is expressed in neurogenic areas where also NSC are located and it has been shown that EGFR is involved in regulation of NSC proliferation, migration, and differentiation. This led us to speculate if EGFR and EGFRvIII are involved in the regulation of bCSC. In this study we use GBM neurosphere cultures, known to preserve bCSC features. We demonstrate that EGFR and EGFRvIII are downregulated upon differentiation and moreover that when EGFR signaling is abrogated, differentiation is induced. Furthermore, we show that differentiation leads to decreased tumorigenic and stem cell-like potential of the neurosphere cultures and that by specifically inhibiting EGFR signaling it is possible to target the bCSC population. Our results suggest that differentiation therapy, possibly along with anti-EGFR treatment would be a feasible treatment option for patients with GBM, by targeting the bCSC population.

Original languageEnglish
JournalCancer Biology & Therapy
Volume15
Issue number2
Pages (from-to)216-24
Number of pages9
ISSN1538-4047
DOIs
Publication statusPublished - Feb 2014

    Research areas

  • Animals, Brain Neoplasms, Cell Differentiation, Cell Line, Tumor, Culture Media, Serum-Free, Down-Regulation, Glioblastoma, Heterografts, Humans, Mice, Neoplastic Stem Cells, Receptor, Epidermal Growth Factor, Tretinoin

ID: 44975141